Drug repurposing using real-world data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug repurposing using real-world data

Published:2023-01 Issue:1 Volume:28 Page:103422
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Tan George S.Q.,Sloan Erica K.,Lambert Pete,Kirkpatrick Carl M.J.,Ilomäki Jenni

Funder

National Breast Cancer Foundation

Monash University

National Health and Medical Research Council

Cancer Council Victoria

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference60 articles.

1. Drug repurposing: an emerging tool for drug reuse, recycling and discovery;Roy;Curr Drug Res Rev,2021

2. Drug repurposing: a promising tool to accelerate the drug discovery process;Parvathaneni;Drug Discov Today,2019

3. Drug repurposing: progress, challenges and recommendations;Pushpakom;Nat Rev Drug Discov,2019

4. Giving drugs a second chance: overcoming regulatory and financial hurdles in repurposing approved drugs as cancer therapeutics;Hernandez;Front Oncol,2017

5. Computational drug repositioning: from data to therapeutics;Hurle;Clin Pharmacol Ther,2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifunctional CoCe/silica and CoMnCe/silica spinel ferrite nanocomposite: in vitro and in vivo evaluation for cancer therapy;Nano-Structures & Nano-Objects;2024-09

2. Risk of Congenital Anomalies Associated with Psychotropic Medications: A Review of Neonatal Reports in the FDA Adverse Event Reporting System (FAERS);2024-05-13

3. A systematic analysis of the contribution of genetics to multimorbidity and comparisons with primary care data;2024-05-13

4. The dark side of drug repurposing. From clinical trial challenges to antimicrobial resistance: analysis based on three major fields;Drug Target Insights;2024-05-10

5. Antibacterial Activity and Mechanism of Candesartan Cilexetil against Enterococcus faecalis;ACS Omega;2024-05-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3